{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:17:10Z","timestamp":1791037030812,"version":"4.1.0"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T00:00:00Z","timestamp":1338336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038361","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T21:38:54Z","timestamp":1338413934000},"page":"e38361","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["BRCA2 Mutations and Triple-Negative Breast Cancer"],"prefix":"10.1371","volume":"7","author":[{"given":"Peter","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"H\u00f6gel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Eiermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyhan","family":"Ataseven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,30]]},"reference":[{"issue":"20","key":"ref1","first-page":"1938","article-title":"Triple-negative breast cancer.","author":"WD Foulkes","year":"2010"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","article-title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.","volume":"9","author":"SR Young","year":"2009","journal-title":"BMC Cancer"},{"issue":"8","key":"ref3","first-page":"520","article-title":"Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer.","author":"DG Evans","year":"2011"},{"issue":"5","key":"ref4","first-page":"1082","article-title":"Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.","author":"AM Gonzalez-Angulo","year":"2011"},{"issue":"1","key":"ref5","first-page":"185","article-title":"Relative contributions of BRCA1 and BRCA2 mutations to \u201ctriple-negative\u201d breast cancer in Ashkenazi Women.","author":"E Comen","year":"2011"},{"issue":"1","key":"ref6","first-page":"118","article-title":"American Society of Clinical Oncology\/College of Ameri-can Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.","author":"AC Wolff","year":"2007"},{"issue":"3","key":"ref7","article-title":"Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and\/or ovar-ian cancer families in Southern Germany.","author":"P Meyer","year":"2003"},{"key":"ref8"},{"key":"ref9","article-title":"Mammakarzinome.","author":"I Bauerfeind","year":"2011"},{"issue":"2","key":"ref10","first-page":"53","article-title":"Genetic testing for familial\/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.","author":"D Gadzicki","year":"2011"},{"issue":"7","key":"ref11","first-page":"602","article-title":"Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.","author":"AC Antoniou","year":"2005"},{"issue":"23","key":"ref12","first-page":"1694","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.","author":"HA Risch","year":"2006"},{"issue":"3","key":"ref13","first-page":"E1200","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.","author":"A Borg","year":"2010"},{"issue":"1","key":"ref14","first-page":"134","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA).","author":"N Mavaddat","year":"2012"},{"issue":"4","key":"ref15","first-page":"447","article-title":"Identification and in silico analysis of functional SNPs of the BRCA1 gene.","author":"R Rajasekaran","year":"2007"},{"issue":"4","key":"ref16","first-page":"250","article-title":"Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.","author":"R Krupa","year":"2009"},{"key":"ref17","author":"Network National Comprehensive Cancer","year":"2011"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T06:39:40Z","timestamp":1540276780000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038361"}},"subtitle":[],"editor":[{"given":"Amanda Ewart","family":"Toland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,30]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038361","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,30]]}}}